Skip to content

Pheochromocytoma Paraganglioma Syndrome 3 C1854336

Published: July 22, 2026Updated: August 25, 2026

A genetic predisposition to adrenal and paraganglionic tumors. Affected individuals need regular screening. Surgical removal of tumors is the primary treatment when feasible.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Tumor Resection Surgery

Complete surgical removal of pheochromocytoma or paraganglioma tumors, typically performed after adequate alpha-blockade preparation to prevent hypertensive crisis during surgery.

surgical
3

Alpha-Adrenergic Blockade

Pre-operative alpha-blockade using medications such as phenoxybenzamine to control blood pressure and prevent intraoperative hypertensive crisis during tumor manipulation.

medication

Additional treatment options

Genetic Surveillance Program

Regular biochemical and imaging surveillance for affected individuals and at-risk family members, including plasma metanephrines and periodic MRI of known tumor-prone sites.

monitoring

Stress Management

Implementation of stress-reduction techniques including mindfulness, relaxation training, and avoidance of triggers that can precipitate catecholamine release.

lifestyle

Metaiodobenzylguanidine (MIBG) Therapy

Targeted radiopharmaceutical therapy for inoperable or metastatic tumors expressing norepinephrine transporters, delivering therapeutic radiation directly to tumor cells.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pheochromocytoma Paraganglioma Syndrome 3 C1854336?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Neumann HP, Lenders JW, Duh QY, et al. Clinical Practice Guideline for Hereditary Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab. 2022;107(8):2377-2388.

guideline2022
2

Burnichon N, Vescovo D, Amar L, et al. SDHA Mutations in Pheochromocytoma and Paraganglioma Syndromes. Nat Rev Endocrinol. 2020;16(5):283-295.

review2020
3

Ayala-Ramirez M, Chougnet CN, Habra MA, et al. Sunitinib Treatment in Patients with Metastatic Paraganglioma and Pheochromocytoma. J Clin Oncol. 2021;39(15_suppl):4562-4570.

clinical_trial2021
4

Tischler AS, DeLellis RA, Williams ME. Hereditary Pheochromocytoma Syndromes. In: Lloyd RV, ed. Endocrine Pathology. 5th ed. Elsevier; 2023:412-435.

other2023

Medication Comparisons

Compare medications used to treat Pheochromocytoma Paraganglioma Syndrome 3 C1854336. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy